2006 annual financial data
Rigel Pharmaceuticals 2006 Operating margin
Direct answer
Operating margin was -128.6%.
Operating income was -43,047,000 USD and net income was -37,637,000 USD.
Operating cash flow was -35,836,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,473,000 USD
- Operating income
- -43,047,000 USD
- Net income
- -37,637,000 USD
- Operating cash flow
- -35,836,000 USD